The latest news from Asia and the Pacific

Provided by AGP

The Asia Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Asia Reporter.

Press releases published on March 19, 2026

Renewable energy adoption accelerating the Biomethane Market 2026
Aviation and Defense Cyber Security Market 2026 reinforcing protection against advanced cyber threats
2026 Inspiring Workplaces Awards Finalists announced across Asia
Best-in-Class Abatement System Exceeds GHG Benchmarks Outlined in Semiconductor Climate Consortium Whitepaper
Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
Damora Therapeutics Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
Curia erweitert seine Produktionskapazitäten in Glasgow und verbessert seine Plattform zur Entwicklung von Zelllinien
Curia renforce ses capacités de production à Glasgow et consolide sa plateforme de développement de lignées cellulaires
קוריה מרחיבה את כושר הייצור של גלזגו ומשפרת את פלטפורמת פיתוח קווי התאים
Curia Memperluas Kapasitas Manufaktur Glasgow dan Meningkatkan Platform Pengembangan Lini Sel
Curia amplía la capacidad de fabricación en Glasgow y mejora su plataforma de desarrollo de líneas celulares
キュリア、グラスゴーの製造能力を拡大し、細胞株開発プラットフォームを強化
Curia Memperluas Kapasiti Pembuatan di Glasgow dan Mempertingkat Platform Pembangunan Garis Sel
Curia Expande Capacidade de Fabricação de Glasgow e Aprimora Plataforma de Desenvolvimento de Linhagem Celular
Curia ขยายขีดความสามารถในการผลิต ณ เมืองกลาสโกว์ พร้อมยกระดับแพลตฟอร์มการพัฒนาเซลล์ไลน์
Curia 扩大格拉斯哥产能并改进细胞系开发平台
Curia, 글래스고 생산 능력 확대 및 세포주 개발 플랫폼 고도화
Curia 擴充格拉斯哥製造產能並升級細胞系開發平台
SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results

Share us

on your social networks:

Sign up for:

The Asia Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.